Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close
  • Discoverability Visible
  • Join Policy Restricted
  • Created 22 Jan 2014

PSON0001 Genomic Characterization of Cell Lines

PSON0001 Genomic Characterization of Cell Lines This study provides genomic characterization of 39 cell lines from Physical Sciences Oncology Center (PS-OC) Network Bioresource Core Facility (PBCF) through the sequencing of mRNA (TruSeq Stranded RNA Sample Preparation Kit), miRNA (TruSeq Small Total RNA Sample Prep Kit ) and exome ( Agilent SureSelectXT2 Human All Exon V5 kit) and aligning to a reference genome (HG19/37 ). Software for the mRNA characterizations included: cufflinks, cuffdecoder, fastcqReports, mapsplice, tophat, transdecoder, for miRNA included: bowtie2, miRanalyzer, miTools. and for exome included bowtie2. Datasets include the output specific to these software packages, as well as more widely used bioinformatics formats: bam, bed, fasta, fastq, vcf (4.1).

Download the dataset at ftp://caftpd.nci.nih.gov/psondcc/CellLineGenomics/

Access the BioProject at NCBI, with links to their entries at NCBI’s Short Read Archive (SRA) and BioSample database.

Table 1. 39 Cell lines used in PSON0001 Genomic Characterization of Cell Lines

cell_line culture_collection tissue cell_type disease disease_stage
NCI-PBCF-1000 ATCC:CRL-10317 BREAST EPITHELIAL FIBROCYSTIC DISEASE
NCI-PBCF-1001 ATCC:HTB-22 BREAST EPITHELIAL ADENOCARCINOMA
NCI-PBCF-CCL227 ATCC:CCL-227 COLON EPITHELIAL ADENOCARCINOMA
NCI-PBCF-CCL228 ATCC:CCL-228 COLON EPITHELIAL ADENOCARCINOMA
NCI-PBCF-CCL229 ATCC:CCL-229 COLON EPITHELIAL ADENOCARCINOMA GRADE IV
NCI-PBCF-CCL247 ATCC:CCL-247 COLON EPITHELIAL CARCINOMA
NCI-PBCF-CCL256.1 ATCC:CCL-256 LUNG EPITHELIAL ADENOCARCINOMA
NCI-PBCF-CCL256 ATCC:CCL-256 LUNG EPITHELIAL ADENOCARCINOMA
NCI-PBCF-CRL-2336 ATCC:CRL-2336 BREAST EPITHELIAL PRIMARY DUCTAL CARCINOMA TNM STAGE IIB GRADE 3
NCI-PBCF-CRL11609 ATCC:CRL-11609 PROSTATE EPITHELIAL NORMAL
NCI-PBCF-CRL1435 ATCC:CRL-1435 PROSTATE EPITHELIAL ADENOCARCINOMA GRADE IV
NCI-PBCF-CRL1469 ATCC:CRL-1469 PANCREAS EPITHELIAL EPITHELIOID CARCINOMA
NCI-PBCF-CRL1500 ATCC:CRL-1500 BREAST EPITHELIAL DUCTAL CARCINOMA
NCI-PBCF-CRL1619 ATCC:CRL-1619 SKIN EPITHELIAL MALIGNANT MELANOMA
NCI-PBCF-CRL1676 ATCC:CRL-1676 SKIN EPITHELIAL MELANOMA
NCI-PBCF-CRL1690 ATCC:CRL-1690 BRAIN FIBROBLAST GLIOBLASTOMA MULTIFORME
NCI-PBCF-CRL1740 ATCC:CRL-1740 PROSTATE EPITHELIAL CARCINOMA
NCI-PBCF-CRL2503 ATCC:CRL-2503 LUNG EPITHELIAL NORMAL
NCI-PBCF-CRL2505 ATCC:CRL-2505 PROSTATE EPITHELIAL CARCINOMA
NCI-PBCF-CRL2876 ATCC:CRL-2876 PROSTATE EPITHELIAL CANCER
NCI-PBCF-CRL4010 ATCC:CRL-4010 BREAST EPITHELIAL-LIKE NORMAL
NCI-PBCF-CRL4023 ATCC:CRL-4023 PANCREAS EPITHELIAL-LIKE NORMAL
NCI-PBCF-CRL5922 ATCC:CRL-5922 LUNG EPITHELIAL-LIKE AND/OR ROUNDED ADENOCARCINOMA STAGE 1
NCI-PBCF-CRL5965 ATCC:CRL-5965 PERIPHERAL BLOOD LYMPHOBLAST NORMAL
NCI-PBCF-HTB123 ATCC:HTB-123 BREAST EPITHELIAL CARCINOMA
NCI-PBCF-HTB132 ATCC:HTB-132 BREAST EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB133 ATCC:HTB-133 BREAST EPITHELIAL DUCTAL CARCINOMA
NCI-PBCF-HTB14 ATCC:HTB-14 BRAIN EPITHELIAL GLIOBLASTOMA; ASTROCYTOMA GRADE IV
NCI-PBCF-HTB161 ATCC:HTB-161 OVARY EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB22 ATCC:HTB-22 BREAST EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB26 ATCC:HTB-26 BREAST EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB37 ATCC:HTB-37 COLON EPITHELIAL-LIKE ADENOCARCINOMA
NCI-PBCF-HTB38 ATCC:HTB-38 COLON EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB65 ATCC:HTB-65 SKIN FIBROBLAST MALIGNANT MELANOMA
NCI-PBCF-HTB68 ATCC:HTB-68 SKIN POLYGONAL MALIGNANT MELANOMA
NCI-PBCF-HTB75 ATCC:HTB-75 OVARY EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB77 ATCC:HTB-77 OVARY EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB79 ATCC:HTB-79 PANCREAS EPITHELIAL ADENOCARCINOMA
NCI-PBCF-HTB81 ATCC:HTB-81 PROSTATE EPITHELIAL CARCINOMA


Data usage policy

The data contained within the PS-ON DCC is based on several research projects and is intended to be rapidly and constantly updated for the research community to access and use. The NCI requests that any data users:

  • Inform the data submitters about the intention to submit a publication that uses PS-ON DCC data.
    • Include the following statement in any publications resulting from the use of PS-ON DCC data: Data used in this publication were generated by projects sponsored by the NCI Physical Sciences in Oncology Initiative.

Created on , Last modified on